晚期乳癌電子報分類文章　顯示方式：簡文 | 列表

2009年07月29日

晚期乳癌電子報第 231 期

截瘤達併用新型標靶治療藥物治療轉移乳癌：理論依據與臨床試驗結果
Capecitabine in Combination with Novel Targeted Agents in the Management of Metastatic Breast Cancer: Underlying Rationale and Results of Clinical Trials
The Oncologist, Vol. 12, No. 4, 375-389, April 2007
...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 23:05 │ 回應(0) │ 引用(0)

晚期乳癌電子報第 230 期

綠茶與乳癌之預防
Green tea and the prevention of breast cancer: a case-control study
Carcinogenesis 2007 28(5):1074-1078
（這是西澳大學與浙江大學合作的研究） ...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 23:03 │ 回應(0) │ 引用(0)

晚期乳癌電子報第 229 期

使用紅血球生成素治療貧血之癌症病人
Results from a Phase III, randomized, double-blind, placebo-controlled study of darbepoetin alfa for the treatment of anemia in patients not receiving chemotherapy or radiotherapy

2007 AACR Annual Meeting ...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 23:01 │ 回應(0) │ 引用(0)

晚期˙乳癌電子報第 228 期

併用聚乙烯二醇化的微脂體doxoubicin與健澤治療接受過化學治療的晚期乳癌病人：第二期試驗
Phase II trial of pegylated liposomal doxorubicin (Caelyx) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer
Acta Oncologica, Volume 46,Issue 2 2007 , pages 208 - 213 ...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 23:00 │ 回應(0) │ 引用(0)

晚期˙乳癌電子報第 226、227 期

紫杉醇的副作用
Managing taxane toxicities
Maurie Markman
Support Care Cancer (2003) 11:144–147 ...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 22:34 │ 回應(0) │ 引用(0)

晚期乳癌電子報 第 225 期

可能與癌症惡化有關的生長因子TGF-beta
April 6, 2007
http://www.mc.vanderbilt.edu/reporter/index.html?ID=5454 ...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 22:32 │ 回應(0) │ 引用(0)

晚期乳癌電子報 第 221-224 期

HER2 therapy. Small molecule HER-2 tyrosine kinase inhibitors
針對HER2的治療：小分子HER-2酪胺酸激脢抑制劑

Breast Cancer Research 2007, 9:205 ...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 22:23 │ 回應(0) │ 引用(0)

晚期乳癌電子報 第 220 期

Pazopanib：新的多種酪胺酸激脢抑制劑

Pazopanib: A Novel Multitargeted Tyrosine Kinase Inhibitor
Guru Sonpavde and Thomas E. Hutson
Current Oncology Reports 2007, 9:115-119 ...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 21:00 │ 回應(0) │ 引用(0)

晚期乳癌電子報 第 219 期

併用健澤與vinorelbine與單僅使用vinorelbine治療，對於接受過anthracycline類藥物與紫杉醇類藥物治療的轉移乳癌病人的效果

Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial

Volume 8, Issue 3 , March 2007, Pages 219-225 ...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 20:59 │ 回應(0) │ 引用(0)

晚期乳癌電子報 第 218 期

併用letrozole與Herceptin作為HER2陽性與雌激素受體陽性的晚期乳癌病人之第一線或第二線治療，病情可以達致相當期間的反應
The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers
P. Kelly Marcom, Claudine Isaacs, Lyndsay Harris, Zee Wang Wong, Aruna Kommarreddy, Nellie Novielli, Gretchen Mann, Yu Tao and Matthew J. Ellis
Breast Cancer Research and Treatment Volume 102, Number 1 / March, 2007 Pages 43-49 ...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 20:58 │ 回應(0) │ 引用(0)
 [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8]  [9]  [10]  [下10頁]  [最終頁] 
回頁首▲